Dr. Francesc Balaguer’s candidature was suggested by the Asociación Española de Gastroenterología. He is leading the High Risk Colorectal Cancer Clinic in the Hospital Clínic of Barcelona and has a broad background in translational colorectal cancer research. His area of interest are the clinical characterization of hereditary colorectal cancer syndromes (i.e. Lynch syndrome), understanding the epigenetic basis of colorectal cancer carcinogenesis, and the development of epigenetic biomarkers for the early diagnosis of colorectal cancer.
Dr. Augusto Villanueva’s candidature was suggested by the Sociedad Española de Patología Digestiva. His research interests are basically aimed to improve prognosis prediction in hepatocellular carcinoma (HCC) by incorporating information from high-throughput genomic platforms into clinical-based prognostic systems. Additionally, he seeks to identify novel targets for therapies by dense scrutiny of signaling pathways (e.g., MTOR, NOTCH). Ultimately, he envisions deploying molecular medicine approaches in routine clinical management of HCC patients.